TEST BANK For Edmunds' Pharmacology for the Primary
Care Provider, 5th Edition by Constance G Visovsky,
Complete Chapters 1 – 25
,Table of Contents
Chapter 01 Prescriptive Authority and Role Implementation Tradition vs.
Change 1
Chapter 02 Historical Review of Prescriptive Authority The Role of Nurses (NPs,
CNMs, CRNAs, and CNSs) and Physician Assistant 3
Chapter 03 General Pharmacokinetic and Pharmacodynamic Principles 5
Chapter 04 Special Populations Geriatrics 9
Chapter 05 Special Populations Pediatrics 12
Chapter 06 Special Populations Pregnant and Nursing Women 16
Chapter 07 Over-the-Counter Medications 19
Chapter 08 Complementary and Alternative Therapies 22
Chapter 09 Establishing the Therapeutic Relationship 25
Chapter 10 Practical Tips on Writing Prescriptions 28
Chapter 11 Evidence-Based Decision Making and Treatment Guidelines 31
Chapter 12 Design and Implementation of Patient Education 35
Chapter 13 Dermatologic Agents 38
Chapter 14 Eye, Ear, Throat, and Mouth Agents 43
Chapter 15 Upper Respiratory Agents 46
Chapter 16 Asthma and Chronic Obstructive Pulmonary Disease Medications 49
Chapter 17 Hypertension and Miscellaneous Antihypertensive Medications 53
Chapter 18 Coronary Artery Disease and Antianginal Medications 56
Chapter 19 Heart Failure and Digoxin 59
Chapter 20 Beta-Blockers 62
Chapter 21 Calcium Channel Blockers 65
Chapter 22 ACE Inhibitors and Angiotensin Receptor Blockers 68
Chapter 23 Antiarrhythmic Agents 71
Chapter 24 Antihyperlipidemic Agents 74
Chapter 25 Agents that Act on Blood 77
Chapter 26 Antacids and the Management of GERD 81
Chapter 27 Histamine-2 Blockers and Proton Pump Inhibitors 84
Chapter 28 Laxatives 87
Chapter 29 Antidiarrheals 90
Chapter 30 Antiemetics 93
Chapter 31 Medications for Irritable Bowel Syndrome and Other Gastrointestinal
Problems 96
Chapter 32 Diuretics 99
Chapter 33 Male Genitourinary Agents 103
Chapter 34 Drugs for Urinary Incontinence and Urinary Analgesia 106
Chapter 35 Acetaminophen 109
Chapter 36 Aspirin and Nonsteroidal Antiinflammatory Drugs 111
Chapter 37 Disease-Modifying Antirheumatic Drugs and Immune Modulators
115
Chapter 38 Gout Medications 119
Chapter 39 Osteoporosis Treatment 122
Chapter 40 Muscle Relaxants 125
Chapter 41 Medications for Attention-Deficit Hyperactivity Disorder 128
Chapter 42 Medications for Dementia 131
,Chapter 43 Analgesia and Pain Management 134
Chapter 44 Migraine Medications 137
Chapter 45 Antiepileptics 141
Chapter 46 Antiparkinson Agents 144
Chapter 47 Antidepressants 147
Chapter 48 Antianxiety and Insomnia Agents 151
Chapter 49 Antipsychotics 154
Chapter 50 Substance Abuse 157
Chapter 51 Glucocorticoids 160
Chapter 52 Thyroid Medications 163
Chapter 53 Diabetes Mellitus Agents 166
Chapter 54 Contraceptives 169
Chapter 55 Hormone Replacement Therapy 173
Chapter 56 Drugs for Breast Cancer 177
Chapter 57 Principles for Prescribing Antiinfectives 179
Chapter 58 Treatment of Specific Infections and Miscellaneous Antibiotics 182
Chapter 59 Penicillins 186
Chapter 60 Cephalosporins 189
Chapter 61 Tetracyclines 192
Chapter 62 Macrolides 194
Chapter 63 Fluoroquinolones 196
Chapter 64 Aminoglycosides 199
Chapter 65 Sulfonamides 201
Chapter 66 Antitubercular Agents 204
Chapter 67 Antifungals 207
Chapter 68 Antiretroviral Medications 209
Chapter 69 Antiviral and Antiprotozoal Agents 211
Chapter 70 The Immune System and Immunizations 214
Chapter 71 Weight Management 220
Chapter 72 Smoking Cessation 223
Chapter 73 Vitamins and Minerals 226
, Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs.
Change Test Bank
MULTIPLE VCHOICE
1. Which Vof Vthe Vfollowing Vhas Vinfluenced Van Vemphasis Von Vprimary Vcare
Veducation Vin V medical Vschools?
a. ChangesVinVMedicare
Vreimbursement V methods
Vrecommended Vin V1992
b. CompetitionVfrom
Vnonphysicians V desiring Vto
Vmeet Vprimary Vcare V shortages
c. The Vneed Vfor Vmonopolistic Vcontrol Vin
Vthe V marketplace Vof Vprimary
Voutpatient Vcare
d. TheVrecognitionVthat
Vnonphysicians V have Vvariable
Vsuccess Vproviding V primary Vcare
ANS: V A
The VPhysician VPayment VReview VCommission Vin V1992 Vdirectly Vincreased Vfinancial
V reimbursement Vto Vclinicians Vwho Vprovide Vprimary Vcare. VCoupled Vwith Va Vshortage
Vof V primary Vcare Vproviders, Vthis Vincentive Vled Vmedical Vschools Vto Vplace Vgreater
Vemphasis V on Vpreparing Vprimary Vcare Vphysicians. VCompetition Vfrom
Vnonphysicians Vincreased V coincidentally Vas Vprofessionals Vfrom Vother Vdisciplines
Vstepped Vup Vto Vmeet Vthe Vneeds. V Nonphysicians Vhave Vhad Vincreasing Vsuccess Vat
Vproviding Vprimary Vcare Vand Vhave Vbeen V shown Vto Vbe Vsafe Vand Veffective.
DIF: Cognitive VLevel: VRemembering V(Knowledge) REF: V V 2
2. Which Vof Vthe Vfollowing Vstatements Vis Vtrue Vabout Vthe Vprescribing Vpractices Vof
Vphysicians?
a. Older Vphysicians Vtend Vto Vprescribe
Vmore V appropriate Vmedications Vthan
Vyounger V physicians.
b. Antibiotic Vmedications Vremain Vin Vthe
V top Vfive Vclassifications Vof
Vmedications V prescribed.
c. Most Vphysicians Vrely Von Va
V“therapeutic V armamentarium” Vthat
Vconsists Vof Vless V than V100 Vdrug
Vpreparations Vper V physician.
d. The Vdominant Vform Vof Vdrug
Vinformation V used Vby Vprimary Vcare
Vphysicians V continues Vto Vbe Vthat
Vprovided Vby V pharmaceutical
Vcompanies.
ANS: V D
Even Vthough Vmost Vphysicians Vclaim Vto Vplace Vlittle Vweight Von Vdrug Vadvertisements,
Care Provider, 5th Edition by Constance G Visovsky,
Complete Chapters 1 – 25
,Table of Contents
Chapter 01 Prescriptive Authority and Role Implementation Tradition vs.
Change 1
Chapter 02 Historical Review of Prescriptive Authority The Role of Nurses (NPs,
CNMs, CRNAs, and CNSs) and Physician Assistant 3
Chapter 03 General Pharmacokinetic and Pharmacodynamic Principles 5
Chapter 04 Special Populations Geriatrics 9
Chapter 05 Special Populations Pediatrics 12
Chapter 06 Special Populations Pregnant and Nursing Women 16
Chapter 07 Over-the-Counter Medications 19
Chapter 08 Complementary and Alternative Therapies 22
Chapter 09 Establishing the Therapeutic Relationship 25
Chapter 10 Practical Tips on Writing Prescriptions 28
Chapter 11 Evidence-Based Decision Making and Treatment Guidelines 31
Chapter 12 Design and Implementation of Patient Education 35
Chapter 13 Dermatologic Agents 38
Chapter 14 Eye, Ear, Throat, and Mouth Agents 43
Chapter 15 Upper Respiratory Agents 46
Chapter 16 Asthma and Chronic Obstructive Pulmonary Disease Medications 49
Chapter 17 Hypertension and Miscellaneous Antihypertensive Medications 53
Chapter 18 Coronary Artery Disease and Antianginal Medications 56
Chapter 19 Heart Failure and Digoxin 59
Chapter 20 Beta-Blockers 62
Chapter 21 Calcium Channel Blockers 65
Chapter 22 ACE Inhibitors and Angiotensin Receptor Blockers 68
Chapter 23 Antiarrhythmic Agents 71
Chapter 24 Antihyperlipidemic Agents 74
Chapter 25 Agents that Act on Blood 77
Chapter 26 Antacids and the Management of GERD 81
Chapter 27 Histamine-2 Blockers and Proton Pump Inhibitors 84
Chapter 28 Laxatives 87
Chapter 29 Antidiarrheals 90
Chapter 30 Antiemetics 93
Chapter 31 Medications for Irritable Bowel Syndrome and Other Gastrointestinal
Problems 96
Chapter 32 Diuretics 99
Chapter 33 Male Genitourinary Agents 103
Chapter 34 Drugs for Urinary Incontinence and Urinary Analgesia 106
Chapter 35 Acetaminophen 109
Chapter 36 Aspirin and Nonsteroidal Antiinflammatory Drugs 111
Chapter 37 Disease-Modifying Antirheumatic Drugs and Immune Modulators
115
Chapter 38 Gout Medications 119
Chapter 39 Osteoporosis Treatment 122
Chapter 40 Muscle Relaxants 125
Chapter 41 Medications for Attention-Deficit Hyperactivity Disorder 128
Chapter 42 Medications for Dementia 131
,Chapter 43 Analgesia and Pain Management 134
Chapter 44 Migraine Medications 137
Chapter 45 Antiepileptics 141
Chapter 46 Antiparkinson Agents 144
Chapter 47 Antidepressants 147
Chapter 48 Antianxiety and Insomnia Agents 151
Chapter 49 Antipsychotics 154
Chapter 50 Substance Abuse 157
Chapter 51 Glucocorticoids 160
Chapter 52 Thyroid Medications 163
Chapter 53 Diabetes Mellitus Agents 166
Chapter 54 Contraceptives 169
Chapter 55 Hormone Replacement Therapy 173
Chapter 56 Drugs for Breast Cancer 177
Chapter 57 Principles for Prescribing Antiinfectives 179
Chapter 58 Treatment of Specific Infections and Miscellaneous Antibiotics 182
Chapter 59 Penicillins 186
Chapter 60 Cephalosporins 189
Chapter 61 Tetracyclines 192
Chapter 62 Macrolides 194
Chapter 63 Fluoroquinolones 196
Chapter 64 Aminoglycosides 199
Chapter 65 Sulfonamides 201
Chapter 66 Antitubercular Agents 204
Chapter 67 Antifungals 207
Chapter 68 Antiretroviral Medications 209
Chapter 69 Antiviral and Antiprotozoal Agents 211
Chapter 70 The Immune System and Immunizations 214
Chapter 71 Weight Management 220
Chapter 72 Smoking Cessation 223
Chapter 73 Vitamins and Minerals 226
, Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs.
Change Test Bank
MULTIPLE VCHOICE
1. Which Vof Vthe Vfollowing Vhas Vinfluenced Van Vemphasis Von Vprimary Vcare
Veducation Vin V medical Vschools?
a. ChangesVinVMedicare
Vreimbursement V methods
Vrecommended Vin V1992
b. CompetitionVfrom
Vnonphysicians V desiring Vto
Vmeet Vprimary Vcare V shortages
c. The Vneed Vfor Vmonopolistic Vcontrol Vin
Vthe V marketplace Vof Vprimary
Voutpatient Vcare
d. TheVrecognitionVthat
Vnonphysicians V have Vvariable
Vsuccess Vproviding V primary Vcare
ANS: V A
The VPhysician VPayment VReview VCommission Vin V1992 Vdirectly Vincreased Vfinancial
V reimbursement Vto Vclinicians Vwho Vprovide Vprimary Vcare. VCoupled Vwith Va Vshortage
Vof V primary Vcare Vproviders, Vthis Vincentive Vled Vmedical Vschools Vto Vplace Vgreater
Vemphasis V on Vpreparing Vprimary Vcare Vphysicians. VCompetition Vfrom
Vnonphysicians Vincreased V coincidentally Vas Vprofessionals Vfrom Vother Vdisciplines
Vstepped Vup Vto Vmeet Vthe Vneeds. V Nonphysicians Vhave Vhad Vincreasing Vsuccess Vat
Vproviding Vprimary Vcare Vand Vhave Vbeen V shown Vto Vbe Vsafe Vand Veffective.
DIF: Cognitive VLevel: VRemembering V(Knowledge) REF: V V 2
2. Which Vof Vthe Vfollowing Vstatements Vis Vtrue Vabout Vthe Vprescribing Vpractices Vof
Vphysicians?
a. Older Vphysicians Vtend Vto Vprescribe
Vmore V appropriate Vmedications Vthan
Vyounger V physicians.
b. Antibiotic Vmedications Vremain Vin Vthe
V top Vfive Vclassifications Vof
Vmedications V prescribed.
c. Most Vphysicians Vrely Von Va
V“therapeutic V armamentarium” Vthat
Vconsists Vof Vless V than V100 Vdrug
Vpreparations Vper V physician.
d. The Vdominant Vform Vof Vdrug
Vinformation V used Vby Vprimary Vcare
Vphysicians V continues Vto Vbe Vthat
Vprovided Vby V pharmaceutical
Vcompanies.
ANS: V D
Even Vthough Vmost Vphysicians Vclaim Vto Vplace Vlittle Vweight Von Vdrug Vadvertisements,
